The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection.
Lehner
Thomas
T
Peter Gorer Department of Immunobiology, Guy's, King's & St Thomas' School of Medicine, Guy's Hospital, London SE1 9RT, UK.
D000818:Animals; D000906:Antibodies / Q000276:immunology; D015704:CD4 Antigens / Q000276:immunology*; D054407:Chemokine CCL4; D018946:Chemokine CCL5 / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007110:Immunity, Active / Q000276:immunology; D007113:Immunity, Innate / Q000276:immunology; D008024:Ligands; D019402:Macrophage Inflammatory Proteins / Q000276:immunology*; D019713:Receptors, CCR5 / Q000235:genetics / Q000276:immunology*; D019718:Receptors, CXCR4 / Q000276:immunology*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology
D000906:Antibodies; D015704:CD4 Antigens; D054407:Chemokine CCL4; D018946:Chemokine CCL5; D008024:Ligands; D019402:Macrophage Inflammatory Proteins; D019713:Receptors, CCR5; D019718:Receptors, CXCR4